Study of Species Distribution and Antifungal Susceptibility of Candida Isolates from Bloodstream Infection in the ICU of a Tertiary Care Hospital of Rajasthan
International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)
DOI: 10.25258/ijcpr.18.7.135 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Shalini Gupta und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Candida bloodstream infections (candidemia) are an important cause of healthcare-associated infections in intensive care units (ICUs), contributing to significant morbidity, mortality, prolonged hospitalization, and increased healthcare costs. The increasing predominance of non-Candida albicans species and the emergence of antifungal resistance have made early species identification and antifungal susceptibility testing essential for effective patient management. Materials and Methods: A cross-sectional study was conducted in which 240 blood culture samples were collected from patients admitted to various ICUs over an 8 month period (from October 2025 to May 2026), were processed for isolation and identification of Candida species using conventional microbiological methods, CHROMagar Candida, cornmeal agar morphology, germ tube test, and confirmation by the VITEK 2 Compact system. Antifungal susceptibility testing was performed by the Kirby–Bauer disk diffusion method following CLSI guidelines.
Results
Among the 240 blood culture samples, 27 (11.3%) yielded Candida species. Non-Candida albicans species accounted for 77.7% of isolates, while Candida albicans comprised 22.3%. Amphotericin B demonstrated the highest susceptibility (81.4%), followed by nystatin (62.96%), whereas fluconazole showed the lowest susceptibility (33.33%).
Conclusion
The study demonstrates a shift towards predominance of non-albicans Candida species with increasing resistance to azole antifungal agents among ICU patients. Early diagnosis, species-level identification, and routine antifungal susceptibility testing are essential for timely initiation of appropriate therapy, optimizing patient outcomes, and reducing the morbidity and mortality associated with candidemia.
Zitieren
APA
Gupta, S., Swami, T., Rajvi, S., & Rawal, A. (2026). Study of Species Distribution and Antifungal Susceptibility of Candida Isolates from Bloodstream Infection in the ICU of a Tertiary Care Hospital of Rajasthan. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.135
Vancouver
Gupta S, Swami T, Rajvi S, Rawal A. Study of Species Distribution and Antifungal Susceptibility of Candida Isolates from Bloodstream Infection in the ICU of a Tertiary Care Hospital of Rajasthan. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.135
BibTeX
@article{Gupta2026,
author = {Gupta, Shalini and Swami, Taruna and Rajvi, Supriya and Rawal, Amit},
title = {Study of Species Distribution and Antifungal Susceptibility of Candida Isolates from Bloodstream Infection in the ICU of a Tertiary Care Hospital of Rajasthan},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {07},
doi = {10.25258/ijcpr.18.7.135}
}
EUVIMED